Old Web
English
Sign In
Acemap
>
authorDetail
>
Shaomei Li
Shaomei Li
Zhengzhou University
Gefitinib
Mucoepidermoid carcinoma
Immunology
JAK-STAT signaling pathway
Biology
4
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial
2019
Translational lung cancer research
Lili Wang
Zhen He
Sen Yang
Hong Tang
Yufeng Wu
Shaomei Li
Baohui Han
Kai Li
Li Zhang
Jianhua Shi
Zhehai Wang
Ying Cheng
Jianxing He
Yuankai Shi
Weiqiang Chen
Yi Luo
Lin Wu
Xiuwen Wang
Kejun Nan
Faguang Jin
Jian Dong
Baolan Li
Yan Sun
Qiming Wang
Show All
Source
Cite
Save
Citations (16)
Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells
2019
Current Cancer Drug Targets
Yufeng Wu
Zhen He
Shaomei Li
Hong Tang
Lili Wang
Sen Yang
Bing Dong
Jianjun Qin
Yue Sun
Han Yu
Yu Zhang
Yi Zhang
Yongjun Guo
Qiming Wang
Show All
Source
Cite
Save
Citations (2)
Gefitinib represses JAK-STAT signaling activated by CRTC1-MAML2 fusion in mucoepidermoid carcinoma cells
2019
Current Cancer Drug Targets
Yufeng Wu
Zhen He
Shaomei Li
Hong Tang
Lili Wang
Sen Yang
Bing Dong
Jianjun Qin
Yue Sun
Han Yu
Yu Zhang
Yi Zhang
Yongjun Guo
Qiming Wang
Show All
Source
Cite
Save
Citations (0)
Pathological complete response to gefitinib in a 10-year-old boy with EGFR-negative pulmonary mucoepidermoid carcinoma: a case report and literature review.
2017
Clinical Respiratory Journal
Shaomei Li
Zhe Zhang
Hong Tang
Zhen He
Yun Gao
Weiguo Ma
Yuxi Chang
Bing Wei
Jie Ma
Kangdong Liu
Zhiyong Ma
Qiming Wang
Show All
Source
Cite
Save
Citations (7)
1